Becton Dickinson, CR Bard deal cleared with conditions in China
China's Ministry of Commerce has conditionally cleared the $24 billion acquisition of C.R. Bard by Becton Dickinson, requiring the divestment of Becton Dickinson’s soft tissue core needle biopsy device business and...To view the full article, register now.
Already a subscriber? Click here to view full article